Skip to main navigation

AnaptysBio

Investor Relations

  • About
    • Overview
    • Strategy
    • Senior Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Contact
  • Science
    • Immune Cell Modulation
    • Anaptys Publications and Relevant Literature
  • Pipeline
    • Overview
    • ANB032
    • Rosnilimab
    • ANB033
    • ANB101
    • Imsidolimab
    • Partnerships
  • Investors / News
    • Overview
    • News
    • Presentations & Events
    • Governance
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Investor FAQs
    • Contact
  • Careers
    • Overview
    • Job Openings
    • Core Values
    • Total Reward Program Highlights
    • AnaptysBio Culture
  • Contact
Toggle

Presentations & Events

Presentations & Events

Corporate Presentation

March, 2026

AnaptysBio Corporate Presentation April 2026

Presentation

Past Events

March 11, 2026 2:20 PM EDT

Leerink Global Healthcare Conference

Webcast
March 10, 2026 8:30 AM EDT

Barclays 28th Annual Global Healthcare Conference

Webcast
March 10, 2026

UBS Biotech Summit Miami: Catalyst for Change

March 04, 2026 11:50 AM EST

TD Cowen 46th Annual Health Care Conference

Webcast
February 12, 2026 12:30 PM EST

Piper Sandler Virtual Novel Targets in Immunology Symposium, Virtual

Webcast
February 11, 2026 3:00 PM EST

Guggenheim Emerging Outlook: Biotech Summit 2026, New York, NY

Webcast
October 14, 2025 4:30 PM EDT

ANB033 (CD122 antagonist) Virtual Investor Event

Webcast
Presentation 3.6 MB
September 29, 2025 4:30 PM EDT

Strategic Separation to Maximize Shareholder Value

Webcast
PRESENTATION 627 KB

Tools

  • Print

    Print

  • Email

    Email

  • RSS Feeds

    RSS Feeds

  • Email Alerts

    Email Alerts

  • Investor Contact

    Investor Contact

  • Document Request

    Document Request

 

AnaptysBio, Inc.

10770 Wateridge Circle
Suite 210
San Diego, CA 92121-5801
(858) 362-6295 (ph)
info@anaptysbio.com

  • LinkedIn

Quick Links

  • About
  • Science
  • Investors / News
  • Careers
  • Contact

Pipeline

  • ANB032
  • Rosnilimab
  • ANB033
  • ANB101
  • Imsidolimab
  • Partnerships
© 2023 AnaptysBio, Inc. All Rights Reserved.
Privacy Policy | Terms Of Use